Anti-Idiotope of anti-NeuGc-ganliosides monoclonal antibody

Pre-made anti-Idiotope of anti-NeuGc-ganliosides monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to Idiotope of anti-NeuGc-ganliosides/ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-INN048-Ab-1/ GM-Tg-hg-INN048-Ab-2Anti-Human Idiotope of anti-NeuGc-ganliosides monoclonal antibodyHuman
GM-Tg-rg-INN048-Ab-1/ GM-Tg-rg-INN048-Ab-2Anti-Rat Idiotope of anti-NeuGc-ganliosides monoclonal antibodyRat
GM-Tg-mg-INN048-Ab-1/ GM-Tg-mg-INN048-Ab-2Anti-Mouse Idiotope of anti-NeuGc-ganliosides monoclonal antibodyMouse
GM-Tg-cynog-INN048-Ab-1/ GM-Tg-cynog-INN048-Ab-2Anti-Cynomolgus/ Rhesus macaque Idiotope of anti-NeuGc-ganliosides monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-INN048-Ab-1/ GM-Tg-felg-INN048-Ab-2Anti-Feline Idiotope of anti-NeuGc-ganliosides monoclonal antibodyFeline
GM-Tg-cang-INN048-Ab-1/ GM-Tg-cang-INN048-Ab-2Anti-Canine Idiotope of anti-NeuGc-ganliosides monoclonal antibodyCanine
GM-Tg-bovg-INN048-Ab-1/ GM-Tg-bovg-INN048-Ab-2Anti-Bovine Idiotope of anti-NeuGc-ganliosides monoclonal antibodyBovine
GM-Tg-equg-INN048-Ab-1/ GM-Tg-equg-INN048-Ab-2Anti-Equine Idiotope of anti-NeuGc-ganliosides monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-INN048-Ab-1/ GM-Tg-hg-INN048-Ab-2; GM-Tg-rg-INN048-Ab-1/ GM-Tg-rg-INN048-Ab-2;
GM-Tg-mg-INN048-Ab-1/ GM-Tg-mg-INN048-Ab-2; GM-Tg-cynog-INN048-Ab-1/ GM-Tg-cynog-INN048-Ab-2;
GM-Tg-felg-INN048-Ab-1/ GM-Tg-felg-INN048-Ab-2; GM-Tg-cang-INN048-Ab-1/ GM-Tg-cang-INN048-Ab-2;
GM-Tg-bovg-INN048-Ab-1/ GM-Tg-bovg-INN048-Ab-2; GM-Tg-equg-INN048-Ab-1/ GM-Tg-equg-INN048-Ab-2
Products NameAnti-Idiotope of anti-NeuGc-ganliosides monoclonal antibody
Formatmab
Target NameIdiotope of anti-NeuGc-ganliosides
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-Idiotope of anti-NeuGc-ganliosides monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-463Pre-Made Racotumomab biosimilar, Whole Mab: Anti-Idiotope of Anti-NeuGc-ganliosides therapeutic antibody
    Target AntigenGM-Tg-g-INN048-Ag-1Recombinant multi-species Idiotope of anti-NeuGc-ganliosides protein


    Target information

    Target IDGM-INN048
    Target NameIdiotope of anti-NeuGc-ganliosides
    Gene IDN/A
    Gene Symbol and Synonyms
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, INN Index
    DiseaseN/A
    Gene EnsemblN/A
    Target ClassificationN/A

    The target: Idiotope of anti-NeuGc-ganliosides, gene name: , also named as . .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.